• 62% to 72% of patients experienced relief1

Getting Started with Quadramet®

Oncologist Office Staff  
1. Oncologist writes the referral 2. Faxes patient-signed consent form and Quadramet Benefits Verification to 877-866-2986
3.CBC with platelets, creatinine ordered if one not done within prior week
 
    4. Benefits verification*
  5. Schedules Quadramet injection at a facility licensed to administer radiopharmaceuticals
6. Notifies patient of date and time
7. Schedules a 2-week follow-up with patient
8. Reviews Quadramet information with patient
 
    9. Injection by a Nuclear Medicine physician or Radiation Oncologist licensed to administer radiopharmaceuticals
10. Two-week followup visit with oncologist 11. Blood work done
12. Schedules weekly blood work for the next 6 to 8 weeks or until counts recover
 

*Patient may be eligible for the EUSA Pharma Community Access Patient Program (CAPP) if s/he has no insurance.

Quadramet is administered on Wednesdays, Thursdays and Fridays.

REFERENCES:

  1. Serafini AN, Houston SJ, Resche I, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol. 1998;16:1574-1581.

Q-0254-07